- Home
- FGEN vs PYN Comparison
FGEN vs PYN Comparison
Compare FGEN & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- PYN
- Stock Information
- Founded
- FGEN 1993
- PYN 2002
- Country
- FGEN United States
- PYN United States
- Employees
- FGEN N/A
- PYN N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- FGEN Health Care
- PYN Finance
- Exchange
- FGEN Nasdaq
- PYN Nasdaq
- Market Cap
- FGEN 33.5M
- PYN 30.4M
- IPO Year
- FGEN 2014
- PYN N/A
- Fundamental
- Price
- FGEN $5.30
- PYN $5.22
- Analyst Decision
- FGEN Strong Buy
- PYN
- Analyst Count
- FGEN 1
- PYN 0
- Target Price
- FGEN $250.00
- PYN N/A
- AVG Volume (30 Days)
- FGEN 53.3K
- PYN 19.9K
- Earning Date
- FGEN 08-05-2025
- PYN 01-01-0001
- Dividend Yield
- FGEN N/A
- PYN 5.07%
- EPS Growth
- FGEN N/A
- PYN N/A
- EPS
- FGEN N/A
- PYN N/A
- Revenue
- FGEN $6,996,000.00
- PYN N/A
- Revenue This Year
- FGEN N/A
- PYN N/A
- Revenue Next Year
- FGEN N/A
- PYN N/A
- P/E Ratio
- FGEN N/A
- PYN N/A
- Revenue Growth
- FGEN N/A
- PYN N/A
- 52 Week Low
- FGEN $4.50
- PYN $4.84
- 52 Week High
- FGEN $38.25
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- FGEN 31.98
- PYN 36.70
- Support Level
- FGEN $5.22
- PYN $5.22
- Resistance Level
- FGEN $5.85
- PYN $5.28
- Average True Range (ATR)
- FGEN 0.59
- PYN 0.05
- MACD
- FGEN -0.17
- PYN -0.00
- Stochastic Oscillator
- FGEN 4.72
- PYN 18.18
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.